Corrigendum to: Reducing the Initial Number of Rituximab Maintenance-Therapy Infusions for ANCA-associated Vasculitides: Randomized-Trial Post-Hoc Analysis - Sorbonne Université
Journal Articles Rheumatology Year : 2020

Corrigendum to: Reducing the Initial Number of Rituximab Maintenance-Therapy Infusions for ANCA-associated Vasculitides: Randomized-Trial Post-Hoc Analysis

Benjamin Terrier
Noémie Jourde-Chiche
Pierre Gobert
  • Function : Author
Jean-François Viallard
  • Function : Author
Jean Sibilia
  • Function : Author
  • PersonId : 948651
Xavier Puechal
Luc Mouthon
Loïc Guillevin

Dates and versions

hal-03894245 , version 1 (12-12-2022)

Identifiers

Cite

Pierre Charles, Agnès Dechartres, Benjamin Terrier, Pascal Cohen, Stanislas Faguer, et al.. Corrigendum to: Reducing the Initial Number of Rituximab Maintenance-Therapy Infusions for ANCA-associated Vasculitides: Randomized-Trial Post-Hoc Analysis. Rheumatology, 2020, 59 (10), pp.3119--3119. ⟨10.1093/rheumatology/keaa222⟩. ⟨hal-03894245⟩
21 View
0 Download

Altmetric

Share

More